217 related articles for article (PubMed ID: 21830629)
1. Men's perspectives on selecting their prostate cancer treatment.
Xu J; Dailey RK; Eggly S; Neale AV; Schwartz KL
J Natl Med Assoc; 2011 Jun; 103(6):468-78. PubMed ID: 21830629
[TBL] [Abstract][Full Text] [Related]
2. Quality of physician-patient relationships is associated with the influence of physician treatment recommendations among patients with prostate cancer who chose active surveillance.
Orom H; Homish DL; Homish GG; Underwood W
Urol Oncol; 2014 May; 32(4):396-402. PubMed ID: 24332649
[TBL] [Abstract][Full Text] [Related]
3. Patient perspective on watchful waiting/active surveillance for localized prostate cancer.
Xu J; Neale AV; Dailey RK; Eggly S; Schwartz KL
J Am Board Fam Med; 2012; 25(6):763-70. PubMed ID: 23136314
[TBL] [Abstract][Full Text] [Related]
4. Patient Knowledge and Qualities of Treatment Decisions for Localized Prostate Cancer.
Daum LM; Reamer EN; Ruterbusch JJ; Liu J; Holmes-Rovner M; Xu J
J Am Board Fam Med; 2017; 30(3):288-297. PubMed ID: 28484061
[TBL] [Abstract][Full Text] [Related]
5. Is 'watchful waiting' a real choice for men with prostate cancer? A qualitative study.
Chapple A; Ziebland S; Herxheimer A; McPherson A; Shepperd S; Miller R
BJU Int; 2002 Aug; 90(3):257-64. PubMed ID: 12133062
[TBL] [Abstract][Full Text] [Related]
6. Racial Differences in Treatment Decision-Making for Men with Clinically Localized Prostate Cancer: a Population-Based Study.
Xu J; Janisse J; Ruterbusch J; Ager J; Schwartz KL
J Racial Ethn Health Disparities; 2016 Mar; 3(1):35-45. PubMed ID: 26896103
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.
Davison BJ; Oliffe JL; Pickles T; Mroz L
Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342
[TBL] [Abstract][Full Text] [Related]
8. Treatment decision-making in localized prostate cancer: why patients chose either radical prostatectomy or external beam radiation therapy.
Ihrig A; Keller M; Hartmann M; Debus J; Pfitzenmaier J; Hadaschik B; Hohenfellner M; Herzog W; Huber J
BJU Int; 2011 Oct; 108(8):1274-8. PubMed ID: 21410634
[TBL] [Abstract][Full Text] [Related]
9. [Prostate cancer: how do patients choose their treatment?].
Enel C; Matte A; Berchi C; Binquet C; Cormier L; Lejeune C
Bull Cancer; 2013 Mar; 100(3):191-9. PubMed ID: 23500637
[TBL] [Abstract][Full Text] [Related]
10. When Primary Care Providers (PCPs) Help Patients Choose Prostate Cancer Treatment.
Radhakrishnan A; Grande D; Ross M; Mitra N; Bekelman J; Stillson C; Pollack CE
J Am Board Fam Med; 2017; 30(3):298-307. PubMed ID: 28484062
[TBL] [Abstract][Full Text] [Related]
11. Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey.
Hall JD; Boyd JC; Lippert MC; Theodorescu D
Urology; 2003 Feb; 61(2):402-7. PubMed ID: 12597956
[TBL] [Abstract][Full Text] [Related]
12. 'It's not like you just had a heart attack': decision-making about active surveillance by men with localized prostate cancer.
Volk RJ; McFall SL; Cantor SB; Byrd TL; Le YC; Kuban DA; Mullen PD
Psychooncology; 2014 Apr; 23(4):467-72. PubMed ID: 24243777
[TBL] [Abstract][Full Text] [Related]
13. Treatment decision-making by men with localized prostate cancer: the influence of personal factors.
Berry DL; Ellis WJ; Woods NF; Schwien C; Mullen KH; Yang C
Urol Oncol; 2003; 21(2):93-100. PubMed ID: 12856636
[TBL] [Abstract][Full Text] [Related]
14. Physician role in physical activity for African-American males undergoing radical prostatectomy for prostate cancer.
Williams F; Imm KR; Colditz GA; Housten AJ; Yang L; Gilbert KL; Drake BF
Support Care Cancer; 2017 Apr; 25(4):1151-1158. PubMed ID: 27999951
[TBL] [Abstract][Full Text] [Related]
15. Influence of Men's Personality and Social Support on Treatment Decision-Making for Localized Prostate Cancer.
Reamer E; Yang F; Holmes-Rovner M; Liu J; Xu J
Biomed Res Int; 2017; 2017():1467056. PubMed ID: 28785574
[TBL] [Abstract][Full Text] [Related]
16. The influence of family ties on men's prostate cancer screening, biopsy, and treatment decisions.
Shaw EK; Scott JG; Ferrante JM
Am J Mens Health; 2013 Nov; 7(6):461-71. PubMed ID: 23459024
[TBL] [Abstract][Full Text] [Related]
17. Factors Influencing Men's Choice of and Adherence to Active Surveillance for Low-risk Prostate Cancer: A Mixed-method Systematic Review.
Kinsella N; Stattin P; Cahill D; Brown C; Bill-Axelson A; Bratt O; Carlsson S; Van Hemelrijck M
Eur Urol; 2018 Sep; 74(3):261-280. PubMed ID: 29598981
[TBL] [Abstract][Full Text] [Related]
18. Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer.
Bosco JL; Halpenny B; Berry DL
Health Qual Life Outcomes; 2012 Sep; 10():123. PubMed ID: 23021156
[TBL] [Abstract][Full Text] [Related]
19. Decision-making strategies for patients with localized prostate cancer.
Diefenbach MA; Dorsey J; Uzzo RG; Hanks GE; Greenberg RE; Horwitz E; Newton F; Engstrom PF
Semin Urol Oncol; 2002 Feb; 20(1):55-62. PubMed ID: 11828358
[TBL] [Abstract][Full Text] [Related]
20. Choosing active surveillance versus curative treatment in a population-based survey of men with low-risk prostate cancer.
Xu J; Janisse J; Goodman M
Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36696653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]